Pulmonx to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
February 09, 2022 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 29, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx to Present at the 33rd Annual Piper Sandler Healthcare Conference
November 16, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx to Participate at Upcoming Investor Conferences
November 03, 2021 08:00 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx Reports Third Quarter 2021 Financial Results
November 02, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for severe lung disease,...
Pulmonx to Report Third Quarter 2021 Financial Results on November 2, 2021
October 26, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx to Present at Upcoming September Investor Conferences
August 26, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) today announced the company will be participating in fireside chats at two upcoming virtual...
Pulmonx Reports Second Quarter 2021 Financial Results
August 03, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for severe lung disease,...
Pulmonx Welcomes Two New Board Members, Adding Expertise in Health Technology, Consumer Marketing, and Integrated Healthcare Delivery Networks
August 02, 2021 08:45 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG), a global leader in minimally invasive treatments for severe lung disease, welcomes Alissa Hsu Lynch and...
Pulmonx to Present at the Canaccord Genuity 41st Annual Growth Conference
July 29, 2021 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...